HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.
2nd Edition of International Summit on Hematology and Blood Disorders
March 20-22, 2025
International Summit on
Hematology and Blood Disorders
April 27 -29, 2023 | Online Event
Event Book
Event program
Scientific Program
About
Magnus Group successfully completed “International Summit on Hematology and Blood Disorders (Hematology 2023)” during April 27-28 (Online event) based on the theme of “Transfusing Innovations and Exploring Emerging Concepts in Hematology”
The Hematology 2023 conference organized by Magnus Institution created a platform for brilliant minds to converge and exchange revolutionary ideas. The event featured renowned speakers who delivered insightful presentations, while young researchers, business delegates, and students from around the world added a vibrant and diverse perspective to the discussions. It was an exceptional gathering that showcased the global impact of hematology research and collaboration.
Scientific Committee Members
Stefan Gluck
Global Medical Affairs at Celgene Corporation, United States
A C Matin
Stanford Medical School, United States
Mohamed Alsharedi
Markey Cancer Center at Lexington Clinic, United StatesSpeakers
Sanghoon Lee
Marshall University, United States
Stefan Gluck
Global Medical Affairs at Celgene Corporation, United States
Erin Weigel
Kedrion Biopharma, United States
Brandon Lucke Wold
University of Florida, United States
A C Matin
Stanford Medical School, United States
Madeeha Subhan Waleed
Lower Bucks Hospital, United States
Mehndi Dandwani
Danbury Hospital, United States
Pranavi Sanka
Warren Alpert Medical School of Brown University, United StatesGallery
Pharma Conference 2019 | Paris, France
Pharma Conference 2018 | Rome, Italy
Pharmaceutics Conference 2017 | Valencia, Spain
Reviews
Magnus Group Conferences Reveiws
Pharma Conference 2017 | Valencia, Spain
Pharma Conference 2018 | Rome, Italy
Title : Histologic transformation of mantle zone lymphoma to diffuse large B-Cell lymphoma: A case report of disease relapse after Covid-19 infection
Lilija Bancevica, Riga Stradins University, Latvia
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan Lluis Vives Corrons, Institute for Leukaemia Research Josep Carreras, Spain
Title : Covid-19 and erythrocyte groups
Marina Nagervadze, Batumi Shota Rustaveli State University, Georgia
Title : Improving outcomes of curable lymphoma in resource constrained regions
Reena Nair, TATA Medical Centre, India
Title : Role of erythrocytapheresis in sickle cell anemia crisis management: A tertiary care centre experience from Chhattisgarh state of central India
Neelesh Jain, Transfusion Medicine at Balco Medical Centre, India
Title : Achieving 100% blood traceability compliance: A United Kingdom district hospital experience
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom